NCT07366775Completed
A Telenursing Program to Support Diabetes Self-Management
Development of Telenursing for Diabetes Self-Management Education and Support (DSMES) Among Patients With Type 2 Diabetes Mellitus in Thailand: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 26 Jun 2026
Brief summary (registry, in English)
This randomized controlled trial aims to develop and evaluate a telenursing-based Diabetes Self-Management Education and Support (DSMES) program with uncontrolled type 2 diabetes mellitus in Thailand. The program is designed to improve diabetes self-management through nurse-led education, behavioral support, and regular follow-up delivered via telecommunication technologies. Participants with type 2 diabetes and poor glycemic control will be randomly assigned to either an intervention group receiving a 12-week telenursing DSMES program or a control group receiving usual care. The intervention includes an initial in-person education session followed by structured video call follow-ups provided by nurse. The primary outcome of this study is the feasibility of implementing telenursing for DSMES in Thailand. Secondary outcomes include changes in glycemic control (HbA1C , FBG), blood pressure, body mass index, diabetes knowledge, self-care behaviors, coping behaviors, quality of life, healthcare costs, and frequency of acute care use. The findings from this study are expected to provide evidence to support the use of telenursing as an accessible and sustainable approach for diabetes self-management in the Thai healthcare context.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 128 (actual)
- First submitted
- 7 Jan 2026
- Start date
- 25 Feb 2026
- Primary completion date
- 8 Jun 2026
- Lead sponsor
- Chiang Mai University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07366775
What you commit to
- Study type: Interventional
- Participants enrolled: 128
- From 25 Feb 2026 to the primary completion date, 8 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous extensive DSMES exposure
Other illness
- Cognitive or mobility impairments , as assessed by the Thai Mental State Examination (TMSE). A TMSE score below 24 was considered indicative of cognitive impairment (The Nurse Association of Thailand, 2025).
Other
- Insulin-dependent patients
- Requiring special nursing care, such as patients with severe diabetic complications or those who are bedridden.
Who the study is looking for
- People with T2DM
- Adults (age 20-64) and older adults (65 and above)
- Uncontrolled diabetes, as determined by physician based on the diagnostic criteria of HbA1C \> 7%
- Can read and write
- Own a smartphone
- Having internet connectivity
- Able to receive a video call or with assistance from a caregiver
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nong Pa Khrang Municipal Hospital Coordinator of this site? Confirm its status | Chiang Mai | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.